Clinical Trial Update: Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating cytoreductive prostatectomy combined with triple or dual systemic therapy in metastatic hormone-sensitive prostate cancer pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Metastatic Prostate Cancer, Therapy, Directly Observed | Phase 3 | Status: RECRUITING